secwatch.observer — SEC 8-K summary
======================================

Issuer:     NRC HEALTH (NRC)
CIK:        0000070487
Form:       8-K
Filed at:   2024-02-13T23:59:59+00:00
Accession:  0001437749-24-003940
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NRC Q4 2023 EPS $0.36; CFO Karas to retire March 31, dividend $0.12
-------------------------------------------------------------------

- Q4 2023 diluted EPS $0.36 vs $0.27; prior year included $0.10 Canadian exit charge.
- Revenue flat at $38M as new core sales offset non-core revenue declines.
- CFO Kevin Karas to retire effective March 31, 2024; one-year base salary continuation.
- Linda Stacy promoted to Principal Accounting Officer, effective March 31, 2024.
- Quarterly dividend $0.12 per share, payable April 15, 2024, record March 29.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/70487/000143774924003940/0001437749-24-003940-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/70487/000143774924003940/nrc20240209c_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-003940

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer